arrow
D

Deborah K. VanderVeen

Boston Children's Hospital and Harvard Medical School
H指数:41
被引数:5,112

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Rates, Timing, and Predictors of Retreatment Across Risk-Cohorts in Retinopathy of Prematurity: Intravitreal Bevacizumab Injection Versus Laser

早产儿视网膜病变不同风险队列中再治疗率、时机和预测因素:玻璃体腔注射贝伐珠单抗与激光治疗比较

2026-06-270
PRE
Reply

回复

2025-04-160
PRE
Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity Reactivations, Additional Treatments, and 12-Month Outcomes

低剂量和极低剂量贝伐单抗治疗早产儿视网膜病变再激活、额外治疗和12个月预后

2022-10-0114
OA